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Editorial on the Research Topic
Computer-Aided Biodesign Across Scales
INTRODUCTION
Computer-aided design (CAD) has revolutionized many engineering fields, enabling the quick
exploration and testing of designs in silico, that minimizes the need for expensive and laborious
physical assembly and experimentation. We believe that CAD will become similarly important to
synthetic biology. However, synthetic biology presents some unique challenges for CAD, including
the multi-scale structure of biology, the combinatorial complexity of molecular systems due the
low degree of insulation inside cells, the stochastic nature of many biological processes, and our
limited ability to accurately characterize the components of these living systems. Despite these
challenges, numerous advancements are being made toward CAD for many aspects of biodesign.
These advances are accelerating our abilities to efficiently assemble synthetic biological systems and
revealing underlying principles for their effective design. In this Research Topic we have collated a
broad range of original research, perspectives, and reviews covering some of the current approaches
to computer-aided biodesign across scales (Figure 1).
DE NOVO MOLECULAR PREDICTION AND DESIGN
At themolecular level, the design of proteins andDNA sequences posemany challenges, but reliable
modeling at this level will offer the means to scale-up biodesign, moving our focus from single
molecules to complex multi-component systems. To make this step, modeling and design tools
need to be able to recapitulate experimental data.
To address this need, Frenz et al. analyze the ProTherm database, which contains
thermodynamic information about large numbers of protein mutations, to build a broader
understanding of potential biases and to develop a curated subset to improve the prediction of
mutational effects. Such robust inference is at the core of traditional protein design methods and
Yeh et al. push these approaches further by developing an interactive user interface (Elfin UI) to
build proteins and protein complexes with arbitrary shapes from compatible structural building
blocks. These architectures are much larger (in the range of thousands of amino acids) than
routinely designed proteins and begin to cross the boundary from the molecular to the cellular
scale. Modeling tools are also central to the prediction of desirable features at a genetic level.
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Gou et al. describe SSRMMD, an algorithm for identification
of microsatellites (or simple sequence repeats, SSRs) within
genomes to allow for better navigation and comparison
of genomes.
TOWARD THE DESIGN OF CELL-FREE
SYSTEMS AND WHOLE CELLS
Due to the complexity of molecular biology, the molecular
to cell scale is one of the most difficult scales of biology to
design. Designing cells requires computational systems that help
engineers navigate numerous challenges, including the large
number of distinct molecular species involved in extant cells and
the lack of rigid structures or insulation between parts, which
gives rise to an extraordinary number of molecular interactions.
One potential way to circumvent these challenges is to
focus on cell-free systems, which promise to be easier to
construct, control, test, and model. Laohakunakorn highlights
these advantages and describes how the reduced complexity
of cell-free systems could be a powerful training ground for
model-driven design of cells. Due to the limitations of cell-
free systems, many problems will likely require engineering
complete synthetic cells. For example, cells would likely be
easier to deploy in open environments than cell-free systems.
Designing entire cells requires confronting the complexity of
molecular biology. Marucci et al. describe the models that
will be needed to tackle this challenge and how such models
could revolutionize synthetic biology. Achieving suchmodels will
likely require the collaborative efforts of numerous modelers,
experimentalists, and engineers, which in turn will likely require
standards for exchanging information about synthetic biological
FIGURE 1 | Overview of computer-aided biodesign methodologies, tools, and standards used across scales. Although each methodology/tool has been placed at the
specific scale it is commonly used, it should be noted that many can be applied across scales. Lines in the “Standards and Formats” section denote the range of
scales over which the standard/format can be used. BioPAX, Biological Pathway Exchange; BNGL, BioNetGen Language; SBML, Systems Biology Markup
Language; SBOL, Synthetic Biology Open Language; PDB, Protein Data Bank.
systems. Foreseeing this need, McLaughlin et al. report a new
version of the Synthetic Biology Open Language (SBOL) which
is substantially easier to use. McLaughlin et al. anticipate that
the new version of SBOL will accelerate the adoption of SBOL




Most synthetic biology efforts to date have focused on
the design of individual cells with basic functionalities
(e.g., implementing basic logic). However, outside the
lab cells rarely exist in isolation and their ability to
interact through chemical signaling and the inherent
heterogeneity in cellular states across a population due to
environmental perturbations can act as a basis for important
collective behaviors. These emergent properties need to be
understood even for simple synthetic circuits to function
reliably and can even be exploited to create more robust
or scalable distributed biological computations. However,
designing individual cells to exhibit desired population-level
behaviors is challenging, requiring novel computational and
theoretical approaches.
Gorochowski et al. propose that multi-agent modeling could
serve as a design framework for engineering living collectives
and offer a way to better understand the underlying causes
and driving factors of emergent properties in protocellular
systems, developmental programs, disease states and industrial
bioprocesses. Karkaria et al. present additional examples where
the engineering of monocultures in synthetic biology has
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reached a bottleneck. Distributed computing is reviewed as
a theoretical framework for understanding and designing
distributed multicellular systems in biology to overcome these
limitations. They consider a wide range of distributed algorithms
used by biology covering the use of bet hedging, organism
development and bacterial colony formation. Finally, Feliú
et al. present original research spanning biological scales
to understand and tune the patterns that emerge within a
population of cells where each cell contains an identical synthetic
oscillator circuit. They use computational modeling spanning
multiple scales and show how a simplified cellular model
coupled to varying environmental conditions can provide a
convenient design tool that closely matches more complex multi-
agent simulations.
CONCLUSION
Being able to scale our ability to harness biology will be crucial
for addressing the many grand challenges we face, such as shifts
toward sustainable manufacturing, clean energy production, and
new forms of advanced medicine. CAD applied to synthetic
biology is likely to play a key role in realizing these ambitions and
the articles presented in this topic provide a broad introduction
to CADs current role, in addition to a glimpse at its possible
development and integration into the bioengineering practices of
the future.
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